L-2-[13C]oxothiazolidine-4-carboxylic acid: A probe for precursor mobilization for glutathione synthesis

American Journal of Physiology - Endocrinology and Metabolism

Volumn 278, Issue 1 41-1, 2000, Pages

  Fukagawa, Naomi K ^a,b   Hercules, Eswin ^b   Ajami, Alfred M ^c  

^a UNIVERSITY OF VERMONT   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c MassTrace   (United States)

Author keywords

5 oxoprolinase; Breath test; Cysteine prodrug

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; 5 OXOPROLINASE; CARBON DIOXIDE; CYSTEINE; GLUTATHIONE; PARACETAMOL; PRODRUG; PYROGLUTAMIC ACID; 2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID; DIAGNOSTIC AGENT; THIAZOLE DERIVATIVE; THIAZOLIDINE DERIVATIVE;

ADULT; AGED; AGING; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; ENZYME MECHANISM; FEMALE; GLUTATHIONE METABOLISM; HUMAN; HUMAN EXPERIMENT; MALE; METABOLIC RATE; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CALORIMETRY; DRUG ANTAGONISM; KINETICS; METABOLISM; MIDDLE AGED;

ACETAMINOPHEN; ADULT; AGED; BREATH TESTS; CALORIMETRY, INDIRECT; CARBON DIOXIDE; CYSTEINE; FEMALE; GLUTATHIONE; HUMANS; KINETICS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PRODRUGS; PYRROLIDONECARBOXYLIC ACID; THIAZOLES; THIAZOLIDINES;

EID: 0033982656     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2000.278.1.e171     Document Type: Article

References (32)

1. Araki, A., and Y. Sako. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. Sci. 422: 43-52, 1987.
2. Bauman, P. F., T. K. Smith, and T. M. Bray. Effect of dietary protein deficiency and L-2-oxothiazolidine-4-carboxylate on the diurnal rhythm of hepatic glutathione in the rat. J. Nutr. 118: 1048-1054, 1988.
3. Chen, X., and G. Batist. Sensitization effect of L-2-oxothiazolidine-4-carboxylate on tumor cells to melphalan and the role of 5-oxo-L-prolinase in glutathione modulation in tumor cells. Biochem. Pharmacol. 56: 743-749, 1998.
4. Chen, X., G. D. Carystinos, and G. Batist. Potential for selective modulation of glutathione in cancer chemotherapy. Chemico-Biol. Int. 111-112: 263-275, 1998.
5. Chen, X., R. L. Schecter, O. W. Griffith, M. A. Hayward, L. C. Alpert, and G. Batist. Characterization of 5-oxo-L-prolinase in normal tissues of humans and rats: a potential new target for biochemical modulation of glutathione. Cancer Res. 4: 131-138, 1998.
6. Chung, T. K., M. A. Funk, and D. H. Baker. L-2-Oxothiazolidine-4-carboxylate as a cysteine precursor: efficacy for growth and hepatic glutathione synthesis in chicks and rats. J. Nutr. 120: 158-160, 1990.
7. Fukagawa, N. K., A. M. Ajami, and V. R. Young. Plasma methionine and cysteine kinetics in response to an intravenous glutathione infusion in adult man. Am. J. Physiol. Endocrinol. Metab. 270: E209-E214, 1996.
8. Kalayjian, R. C., G. Skowron, R. T. Emgushov, M. Chance, S. A. Spell, P. R. Borum, L. S. Webb, K. H. Mayer, J. B. Jackson, B. Yen-Lieberman, K. O. Story, W. B. Rowe, K. Thompson, D. Goldberg, S. Trimbo, and M. M. Lederman. A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (Procysteine) in asymptomatic HIV-infected subjects. J. AIDS 7: 369-374, 1994.
9. Landriani, G. S., V. Guardabasso, and M. Rocchetti. NL-FIT: a microcomputer program for non-linear fitting. Comput. Programs Biomed. 16: 35-42, 1983.
10. Lang, C. A., S. Naryshkin, D. L. Schneider, B. J. Mills, and R. D. Lindeman. Low blood glutathione levels in healthy aging adults. J. Lab. Clin. Med. 120: 720-725, 1992.
11. Lauterburg, B. H., I. Grattagliano, R. Gmur, M. Stalder, and P. Hildebrand. Noninvasive assessment of the effect of xenobiotics on mitochondrial function in human beings: studies with acetylsalicylic acid and ethanol with the use of the carbon 13-labeled ketoisocaproate breath test. J. Lab. Clin. Med. 125: 378-383, 1995.
12. Leaf, C. D., and G. W. Pace. Development of a novel glutathione repleting agent, L-2-oxothiazolidine-4-carboxylic acid (Procysteine). Exp. Opin. Invest. Drugs 3: 1293-1302, 1994.
13. McNamara, P. J., J. C. Fleishaker, and T. Hayden. Mean residence time in peripheral tissue. J. Pharmacokinet. Biopharm. 15: 439-450, 1987.
14. Meister, A. Mitochondrial changes asssociated with glutathione deficiency. Biochim. Biophys. Acta 1271: 35-42, 1995.
15. Meister, A., and M. E. Anderson. Glutathione. Annu. Rev. Biochem. 52: 711-760, 1983.
16. Meister, A., M. E. Anderson, and O. Hwang. Intracellular cysteine and glutathione delivery systems. J. Am. Coll. Nutr. 5: 137-151, 1986.
17. Meister, A., O. W. Griffith, and J. M. Williamson. 5-Oxo-L-prolinase from rat kidney. Methods Enzymol. 113: 445-451, 1985.
18. 13C-breath test for quantitative assessment of liver function in humans. Hepatogastroenterology 42: 931-938, 1995.
19. Porta, P., S. Aebi, K. Summer, and B. H. Lauterburg. L-2-Oxothiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in humans. J. Pharmacol. Exp. Ther. 257: 331-334, 1991.
20. Reicks, M., R. J. Calvert, and J. N. Hathcock. Effects of prolonged acetaminophen ingestion and dietary methionine on mouse liver glutathione. Drug Nutr. Int. 5: 351-363, 1988.
21. Richie, Jr., J. P. The role of glutathione in aging and cancer. Exp. Gerontol. 27: 615-626, 1992.
22. Ristoff, E., and A. Larsson. Patients with genetic defects in the γ-glutamyl cycle. Chemico-Biol. Int. 111-112: 113-121, 1998.
23. Smith, C. V., D. P. Jones, T. M. Guenthner, L. H. Lash, and B. H. Lauterburg. Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicol. Appl. Pharmacol. 140: 1-12, 1996.
24. Srivenugopal, K. S., and F. Ali-Osman. Activity and distribution of the cysteine prodrug activating enzyme, 5-oxo-L-prolinase, in human normal tumor tissues. Cancer Lett. 117: 105-111, 1997.
25. Tanswell, P., G. Heinzel, H. Weisenberger, and W. Roth. Pharmacokinetic-pharmacodynamic and metabolite modeling with TopFit. Int. J. Clin. Pharmacol. Ther. 33: 550-554, 1995.
26. Taylor, C. G., P. F. Bauman, B. Sikorski, and T. M. Bray. Elevation of lung glutathione by oral supplementation of L-2-oxothiazolidine-4-carboxylate protects against oxygen toxicity in protein-energy malnourished rats. FASEB J. 6: 3101-3107, 1992.
27. Trocino, R. A., S. Akazawa, M. Ishibashi, K. Matsummoto, H. Matsuo, H. Yamamoto, S. Goto, Y. Urata, T. Kondo, and S. Nagataki. Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44: 992-998, 1995.
28. Vendemiale, G., I. Grattagliano, E. Altomare, N. Turturro, and F. Guerrieri. Effect of acetaminophen administration on hepatic glutathione compartmentation and mitochondrial energy metabolism in the rat. Biochem. Pharmacol. 52: 1147-1154, 1996.
29. Wagner, J. G. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to data. J. Pharmacokinet. Biopharm. 4: 443-467, 1976.
30. Wagner, J. G. Pharmacokinetics for the Pharmaceutical Scientist. Lancaster, PA: Technomics, 1993, p. 1-316.
31. Williamson, J. M., B. Boettcher, and A. Meister. Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc. Natl. Acad. Sci. USA 79: 6246-6249, 1982.
32. Williamson, J. M., and A. Meister. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate. Proc. Natl. Acad. Sci. USA 78: 936-939, 1981.